» Articles » PMID: 25438019

Iron and Acinetobacter Baumannii Biofilm Formation

Overview
Journal Pathogens
Date 2014 Dec 2
PMID 25438019
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Acinetobacter baumannii is an emerging nosocomial pathogen, responsible for infection outbreaks worldwide. The pathogenicity of this bacterium is mainly due to its multidrug-resistance and ability to form biofilm on abiotic surfaces, which facilitate long-term persistence in the hospital setting. Given the crucial role of iron in A. baumannii nutrition and pathogenicity, iron metabolism has been considered as a possible target for chelation-based antibacterial chemotherapy. In this study, we investigated the effect of iron restriction on A. baumannii growth and biofilm formation using different iron chelators and culture conditions. We report substantial inter-strain variability and growth medium-dependence for biofilm formation by A. baumannii isolates from veterinary and clinical sources. Neither planktonic nor biofilm growth of A. baumannii was affected by exogenous chelators. Biofilm formation was either stimulated by iron or not responsive to iron in the majority of isolates tested, indicating that iron starvation is not sensed as an overall biofilm-inducing stimulus by A. baumannii. The impressive iron withholding capacity of this bacterium should be taken into account for future development of chelation-based antimicrobial and anti-biofilm therapies.

Citing Articles

Decay experiments and microbial community analysis of water lily leaf biofilms: Sediment effects on leaf preservation potential.

Palmer B, Karacic S, Low S, Janssen K, Farber H, Liesegang M PLoS One. 2024; 19(12):e0315656.

PMID: 39693331 PMC: 11654923. DOI: 10.1371/journal.pone.0315656.


Antimicrobial activity of iron-depriving pyoverdines against human opportunistic pathogens.

Vollenweider V, Rehm K, Chepkirui C, Perez-Berlanga M, Polymenidou M, Piel J Elife. 2024; 13.

PMID: 39693130 PMC: 11655065. DOI: 10.7554/eLife.92493.


Comprehensive Approaches to Combatting Biofilms: From Biofilm Structure to Phage-Based Therapies.

Grygiel I, Bajrak O, Wojcicki M, Krusiec K, Jonczyk-Matysiak E, Gorski A Antibiotics (Basel). 2024; 13(11).

PMID: 39596757 PMC: 11591314. DOI: 10.3390/antibiotics13111064.


A Preliminary Study on the Effect of Deferoxamine on the Disruption of Bacterial Biofilms and Antimicrobial Resistance.

Temel A, Aksoyalp Z Turk J Pharm Sci. 2024; 21(4):267-273.

PMID: 39224041 PMC: 11589088. DOI: 10.4274/tjps.galenos.2023.23890.


Ironing out Persisters? Revisiting the Iron Chelation Strategy to Target Planktonic Bacterial Persisters Harboured in Carbapenem-Resistant .

Yeo J, Begam N, Leow W, Goh J, Zhong Y, Cai Y Microorganisms. 2024; 12(5).

PMID: 38792801 PMC: 11123761. DOI: 10.3390/microorganisms12050972.


References
1.
Minandri F, Bonchi C, Frangipani E, Imperi F, Visca P . Promises and failures of gallium as an antibacterial agent. Future Microbiol. 2014; 9(3):379-97. DOI: 10.2217/fmb.14.3. View

2.
Luo G, Spellberg B, Gebremariam T, Lee H, Xiong Y, French S . Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia. Eur J Clin Microbiol Infect Dis. 2013; 33(5):845-51. PMC: 4090217. DOI: 10.1007/s10096-013-2023-5. View

3.
Eveillard M, Kempf M, Belmonte O, Pailhories H, Joly-Guillou M . Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis. 2013; 17(10):e802-5. DOI: 10.1016/j.ijid.2013.03.021. View

4.
Lee H, Koh Y, Lee J, Lee Y, Seol S, Cho D . Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect. 2007; 14(1):49-54. DOI: 10.1111/j.1469-0691.2007.01842.x. View

5.
OToole G, Kaplan H, Kolter R . Biofilm formation as microbial development. Annu Rev Microbiol. 2000; 54:49-79. DOI: 10.1146/annurev.micro.54.1.49. View